Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countries.
Despite the high burden of hyperlipidemia and the effectiveness of treatment, evidence suggests that the accessibility of hyperlipidemia medicines can be low in many low- and middle-income countries (LMICs). The aim of this study was to identify common barriers to the accessibility of medicines for...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Public Library of Science (PLoS)
2024-01-01
|
| Col·lecció: | PLOS Global Public Health |
| Accés en línia: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0002905&type=printable |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|